Search
for

    Sort by

    Research 871–900 of 1000+

    1. Identification of two additional novel mutations in the AR gene associated with severe forms of androgen insensitivity syndrome Steroids · 2019 · 1 citations
    2. 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis Journal of Investigative Dermatology · 2019 · 1 citations
    3. 77015 Subgroup Analysis of Efficacy of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata From the UP-AA Phase 3 Program Journal of the American Academy of Dermatology · 2026
    4. 74582 Early improvement in scalp hair regrowth with deuruxolitinib in patients with severe alopecia areata: Pooled analysis of the THRIVE-AA1 and THRIVE-AA2 Phase 3 trials Journal of the American Academy of Dermatology · 2026
    5. Adverse effects of baricitinib in comparison to methotrexate in the treatment of severe alopecia areata International Journal of Research in Medical Sciences · 2026
    6. P46 PSYCHOMETRIC PERFORMANCE OF EQ-5D-5L INDEX IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA: EVIDENCE FROM PHASE III TRIAL DATA Value in Health · 2026
    7. Cost‐Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan The Journal of Dermatology · 2026
    8. Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata Journal of Allergy and Clinical Immunology · 2026
    9. Analysis of the Current Status of Acute Postoperative Pain and Influencing Factors of Moderate to Severe Pain in Adult Patients Undergoing Ophthalmic Surgery Under General Anesthesia Journal of Pain Research · 2026
    10. Safety and Efficacy of Mesotherapy with Placenta Polypeptide Injection for Moderate-to-Severe Sensitive Skin: A Multicenter, Randomized, Controlled Trial Clinical Cosmetic and Investigational Dermatology · 2026
    11. Tissue Retinol‐Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment‐Refractory Alopecia Areata: Association With Response to Baricitinib Dermatologic Therapy · 2026
    12. Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials SKIN The Journal of Cutaneous Medicine · 2025
    13. Efficacy of Fire Needle Therapy Combined with Doxycycline Hydrochloride in the Management of Moderate-to-Severe Acne Vulgaris: A Randomized Controlled Trial Journal of Multidisciplinary Healthcare · 2025
    14. Atypical presentation of Acrodermatitis enteropathica in a child: later onset with life-threatening severe extensive dermatitis and septic shock BMC Pediatrics · 2025
    15. RETRACTION: Observing the Clinical Efficacy of Combined Serum Microneedle Therapy for Moderate to Severe Androgenetic Alopecia in Scalp Repair Skin Research and Technology · 2025
    16. Response to Li et al.’s “Therapeutic efficacy of platelet-rich plasma combining with microneedling and topical minoxidil in refractory severe androgenic alopecia” Journal of the American Academy of Dermatology · 2025
    17. Trichoscopic evaluation in oral tofacitinib and oral betamethasone in the treatment of moderate to severe alopecia areata Clinical Medicine · 2025
    18. Therapeutic Efficacy of Platelet-Rich Plasma Combining with Microneedling and Topical Minoxidil in Refractory Severe Androgenic Alopecia Journal of the American Academy of Dermatology · 2024
    19. 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata Journal of the American Academy of Dermatology · 2024
    20. Observing the clinical efficacy of combined serum microneedle therapy for moderate to severe androgenetic alopecia in scalp repair Skin Research and Technology · 2024
    21. Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata Dermatology and Therapy · 2023
    22. 42146 Concurrent improvement in scalp hair and eyebrow or eyelash regrowth in patients with severe alopecia areata treated with baricitinib Journal of The American Academy of Dermatology · 2023
    23. 43364 Long Term Real-World Patient-Reported Outcomes with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry Journal of the American Academy of Dermatology · 2023
    24. Finasteride Induces Epigenetic Alteration of TMPRss2 Gene Expression: A Potential role in Severe Acute Respiratory Syndrome-Corona Virus-2 Inhibition 2023
    25. 738 Cryo-EM and molecular dynamics of TRPV3 channel in activated state reveal structural features implicated in severe itch and hyperkeratosis 2023
    26. Identification of a novel homozygous LAMB3 mutation in a Chinese male with junctional epidermolysis bullosa and severe urethra stenosis: A case report Frontiers in genetics · 2022
    27. Re-discovery of Trichophyton bullosum in North Africa as a cause of severe dermatophytosis in donkeys Folia Microbiologica · 2021
    28. Evaluation of Efficacy and Safety of Oral Cyclosporine in the Treatment of Severe Alopecia Areata Indian Journal of Forensic Medicine & Toxicology · 2020
    29. Compound Heterozygous Mutations in <i>Forkhead Box N1</i> (<i>FOXN1</i>) Lead to a Severe Immunodeficiency but Normal Hair and Nail Development in Patients 2018
    30. PS10:189 Neuropsychiatric lupus. a severe manifestation of systemic lupus erythematosus 2018